Gaucher disease: a lysosomal neurodegenerative disorder.
Gaucher disease is a multisystemic disorder that affects men and woman in equal numbers and occurs in all ethnic groups at any age with racial variations and an estimated worldwide incidence of 1/75,000. It is caused by a genetic deficient activity of the lysosomal enzyme glucocerebrosidase due to mutations in the β-glucocerebrosidase gene, and resulting in lack of glucocerebroside degradation. The subsequent accumulation of glucocerebroside in lysosomes of tissue macrophages primarily in the liver, bone marrow and spleen, causes damage in haematological, skeletal and nervous systems. The clinical manifestations show a high degree of variability with symptoms that varies according to organs involved. In many cases, these disorders do not correlate with mutations in the β-glucocerebrosidase gene. Although several mutations have been identified as responsible for the deficient activity of glucocerebrosidase, mechanisms by which this enzymatic defect leads to Gaucher disease remain poorly understood. Recent reports indicate the implication of complex mechanisms, including enzyme deficiency, substrate accumulation, unfolded protein response, and macrophage activation. Further elucidating these mechanisms will advance understanding of Gaucher disease and related disorders.
Department of Neurology, Xuzhou Central Hospital, Xuzhou, Jiangsu, China. 85252095@qq.com.
W J
WJ
Huang
X
X
Zhang
W W
WW
Chen
D000818:Animals; D005776:Gaucher Disease / Q000175:diagnosis / Q000201:enzymology* / Q000235:genetics*; D005962:Glucosylceramidase / Q000172:deficiency / Q000235:genetics*; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000473:pathology; D020140:Lysosomal Storage Diseases, Nervous System / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics; D009154:Mutation / Q000235:genetics; D019636:Neurodegenerative Diseases / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics
D005962:Glucosylceramidase